secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2026-06-05T20:05:32+00:00
Accession:  0001104659-26-070966
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics fails to convene special meeting due to lack of quorum; will reschedule
--------------------------------------------------------------------------------

- Special Meeting on June 5, 2026, lacked quorum; meeting not convened.
- Company will call a new meeting to seek stockholder approval for warrant exercise proposal.
- Under Inducement Agreement (Oct 2025), seeks approval for issuance of up to 16,184,560 shares upon warrant exercise.
- Unless waived, must call meeting every 60 days until approval obtained or warrants expire.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465926070966/0001104659-26-070966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465926070966/tm2616886d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-070966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer